p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells

Journal of Experimental Medicine

Volumn 210, Issue 10, 2013, Pages 2057-2069

  Iannello, Alexandre ^a   Thompson, Thornton W ^a   Ardolino, Michele ^a   Lowe, Scott W ^b   Raulet, David H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL2 CHEMOKINE; DOXYCYCLINE; INTERLEUKIN 1; INTERLEUKIN 12P40; INTERLEUKIN 18; INTERLEUKIN 6; MESSENGER RNA; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL AGING; CELL INFILTRATION; CONCENTRATION RESPONSE; CYTOKINE PRODUCTION; EX VIVO STUDY; FLOW CYTOMETRY; IMMUNOCOMPETENT CELL; IN VIVO STUDY; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; CELL AGING; CELL LINE, TUMOR; CHEMOKINE CCL2; CHEMOKINES; CYTOTOXICITY, IMMUNOLOGIC; KILLER CELLS, NATURAL; LIGANDS; MICE; MICE, KNOCKOUT; NEOPLASMS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84885458655     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20130783     Document Type: Article

References (51)

1. Acosta, J.C., A. O'Loghlen, A. Banito, M.V. Guijarro, A. Augert, S. Raguz, M. Fumagalli, M. Da Costa, C. Brown, N. Popov, et al. 2008. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell. 133:1006-1018. http://dx.doi.org/10.1016/j.cell.2008.03.038
2. Bavik, C., I. Coleman, J.P. Dean, B. Knudsen, S. Plymate, and P.S. Nelson. 2006. The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Res. 66:794-802. http://dx.doi.org/10.1158/0008-5472 .CAN-05-1716
3. Brady, C.A., D. Jiang, S.S. Mello, T.M. Johnson, L.A. Jarvis, M.M. Kozak, D. Kenzelmann Broz, S. Basak, E.J. Park, M.E. McLaughlin, et al. 2011. Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression. Cell. 145:571-583. http://dx.doi.org/10.1016/j.cell.2011.03.035
4. Braig, M., and C.A. Schmitt. 2006. Oncogene-induced senescence: putting the brakes on tumor development. Cancer Res. 66:2881-2884. http://dx.doi.org/10.1158/0008-5472.CAN-05-4006
5. Braig, M., S. Lee, C. Loddenkemper, C. Rudolph, A.H. Peters, B. Schlegelberger, H. Stein, B. Dörken, T. Jenuwein, and C.A. Schmitt. 2005. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature. 436:660-665. http://dx.doi.org/10.1038/nature03841
6. Cerwenka, A., J.L. Baron, and L.L. Lanier. 2001. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc. Natl. Acad. Sci. USA. 98:11521-11526. http://dx.doi.org/10.1073/pnas.201238598
7. Collado, M., and M. Serrano. 2010. Senescence in tumours: evidence from mice and humans. Nat. Rev. Cancer. 10:51-57. http://dx.doi.org/10.1038/nrc2772
8. Coppé, J.P., K. Kauser, J. Campisi, and C.M. Beauséjour. 2006. Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence. J. Biol. Chem. 281:29568-29574. http://dx.doi.org/10.1074/jbc.M603307200
9. Coppé, J.P., C.K. Patil, F. Rodier, Y. Sun, D.P. Muñoz, J. Goldstein, P.S. Nelson, P.Y. Desprez, and J. Campisi. 2008. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6:2853-2868. http://dx.doi.org/10.1371/journal.pbio.0060301
10. Diefenbach, A., A.M. Jamieson, S.D. Liu, N. Shastri, and D.H. Raulet. 2000. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1:119-126. http://dx.doi.org/10.1038/77793
11. Diefenbach, A., E.R. Jensen, A.M. Jamieson, and D.H. Raulet. 2001. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature. 413:165-171. http://dx.doi.org/10.1038/35093109
12. Diefenbach, A., J.K. Hsia, M.Y. Hsiung, and D.H. Raulet. 2003. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. Eur. J. Immunol. 33:381-391. http://dx.doi.org/10.1002/immu.200310012
13. Gasser, S., S. Orsulic, E.J. Brown, and D.H. Raulet. 2005. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature. 436:1186-1190. http://dx.doi.org/10.1038/nature03884
14. Grégoire, C., L. Chasson, C. Luci, E. Tomasello, F. Geissmann, E. Vivier, and T. Walzer. 2007. The trafficking of natural killer cells. Immunol. Rev. 220:169-182. http://dx.doi.org/10.1111/j.1600-065X.2007.00563.x
15. Guerra, N., Y.X. Tan, N.T. Joncker, A. Choy, F. Gallardo, N. Xiong, S. Knoblaugh, D. Cado, N.M. Greenberg, and D.H. Raulet. 2008. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity. 28:571-580. http://dx.doi.org/10.1016/j.immuni.2008.02.016
16. Hacke, K., B. Rincon-Orozco, G. Buchwalter, S.Y. Siehler, B. Wasylyk, L. Wiesmüller, and F. Rösl. 2010. Regulation of MCP-1 chemokine transcription by p53. Mol. Cancer. 9:82. http://dx.doi.org/10.1186/1476-4598-9-82
17. Hilpert, J., L. Grosse-Hovest, F. Grünebach, C. Buechele, T. Nuebling, T. Raum, A. Steinle, and H.R. Salih. 2012. Comprehensive analysis of NKG2D ligand expression and release in leukemia: implications for NKG2D-mediated NK cell responses. J. Immunol. 189:1360-1371. http://dx.doi.org/10.4049/jimmunol.1200796
18. Jinushi, M., T. Takehara, T. Tatsumi, T. Kanto, V. Groh, T. Spies, R. Kimura, T. Miyagi, K. Mochizuki, Y. Sasaki, and N. Hayashi. 2003. Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid. Int. J. Cancer. 104:354-361. http://dx.doi.org/10.1002/ijc.10966
19. Jung, H., B. Hsiung, K. Pestal, E. Procyk, and D.H. Raulet. 2012. RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry. J. Exp. Med. 209:2409-2422. http://dx.doi.org/10.1084/jem.20120565
20. Kang, T.W., T. Yevsa, N. Woller, L. Hoenicke, T. Wuestefeld, D. Dauch, A. Hohmeyer, M. Gereke, R. Rudalska, A. Potapova, et al. 2011. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature. 479:547-551. http://dx.doi.org/10.1038/nature10599
21. Kortlever, R.M., P.J. Higgins, and R. Bernards. 2006. Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence. Nat. Cell Biol. 8:877-884. http://dx.doi.org/10.1038/ncb1448
22. Krizhanovsky, V., M. Yon, R.A. Dickins, S. Hearn, J. Simon, C. Miething, H. Yee, L. Zender, and S.W. Lowe. 2008. Senescence of activated stellate cells limits liver fibrosis. Cell. 134:657-667. http://dx.doi.org/10.1016/j.cell.2008.06.049
23. Krtolica, A., S. Parrinello, S. Lockett, P.Y. Desprez, and J. Campisi. 2001. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl. Acad. Sci. USA. 98:12072-12077. http://dx.doi.org/10.1073/pnas.211053698
24. Kuilman, T., C. Michaloglou, L.C. Vredeveld, S. Douma, R. van Doorn, C.J. Desmet, L.A. Aarden, W.J. Mooi, and D.S. Peeper. 2008. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell. 133:1019-1031. http://dx.doi.org/10.1016/j.cell.2008.03.039
25. Laberge, R.M., P. Awad, J. Campisi, and P.Y. Desprez. 2012. Epithelialmesenchymal transition induced by senescent fibroblasts. Cancer Microenviron. 5:39-44. http://dx.doi.org/10.1007/s12307-011-0069-4
26. Li, H., T. Lakshmikanth, C. Garofalo, M. Enge, C. Spinnler, A. Anichini, L. Szekely, K. Kärre, E. Carbone, and G. Selivanova. 2011. Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2. Cell Cycle. 10:3346-3358. http://dx.doi.org/10.4161/cc.10.19.17630
27. Liu, D., and P.J. Hornsby. 2007. Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. Cancer Res. 67:3117-3126. http://dx.doi.org/10.1158/0008-5472.CAN-06-3452
28. Lujambio, A., L. Akkari, J. Simon, D. Grace, D.F. Tschaharganeh, J.E. Bolden, Z. Zhao, V. Thapar, J.A. Joyce, V. Krizhanovsky, and S.W. Lowe. 2013. Non-cell-autonomous tumor suppression by p53. Cell. 153:449-460. http://dx.doi.org/10.1016/j.cell.2013.03.020
29. Martinez de la Torre, Y., C. Buracchi, E.M. Borroni, J. Dupor, R. Bonecchi, M. Nebuloni, F. Pasqualini, A. Doni, E. Lauri, C. Agostinis, et al. 2007. Protection against inflammation-and autoantibody-caused fetal loss by the chemokine decoy receptor D6. Proc. Natl. Acad. Sci. USA. 104:2319-2324. http://dx.doi.org/10.1073/pnas.0607514104
30. McGilvray, R.W., R.A. Eagle, N.F. Watson, A. Al-Attar, G. Ball, I. Jafferji, J. Trowsdale, and L.G. Durrant. 2009. NKG2D ligand expression in human colorectal cancer reveals associations with prognosis and evidence for immunoediting. Clin. Cancer Res. 15:6993-7002. http://dx.doi.org/10.1158/1078-0432.CCR-09-0991
31. Michaloglou, C., L.C. Vredeveld, M.S. Soengas, C. Denoyelle, T. Kuilman, C.M. van der Horst, D.M. Majoor, J.W. Shay, W.J. Mooi, and D.S. Peeper. 2005. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature. 436:720-724. http://dx.doi.org/10.1038/nature03890
32. Nardella, C., J.G. Clohessy, A. Alimonti, and P.P. Pandolfi. 2011. Pro-senescence therapy for cancer treatment. Nat. Rev. Cancer. 11:503-511. http://dx.doi.org/10.1038/nrc3057
33. Narita, M., S. Nunez, E. Heard, M. Narita, A.W. Lin, S.A. Hearn, D.L. Spector, G.J. Hannon, and S.W. Lowe. 2003. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell. 113:703-716. http://dx.doi.org/10.1016/S0092-8674(03)00401-X
34. Pace, L., A. Tempez, C. Arnold-Schrauf, F. Lemaitre, P. Bousso, L. Fetler, T. Sparwasser, and S. Amigorena. 2012. Regulatory T cells increase the avidity of primary CD8+ T cell responses and promote memory. Science. 338:532-536. http://dx.doi.org/10.1126/science.1227049
35. Parrinello, S., J.P. Coppe, A. Krtolica, and J. Campisi. 2005. Stromalepithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J. Cell Sci. 118:485-496. http://dx.doi.org/10.1242/jcs.01635
36. Raulet, D.H. 2003. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 3:781-790. http://dx.doi.org/10.1038/nri1199
37. Raulet, D.H., S. Gasser, B.G. Gowen, W. Deng, and H. Jung. 2013. Regulation of ligands for the NKG2D activating receptor. Annu. Rev. Immunol. 31:413-441. http://dx.doi.org/10.1146/annurev-immunol-032712-095951
38. Rodier, F., and J. Campisi. 2011. Four faces of cellular senescence. J. Cell Biol. 192:547-556. http://dx.doi.org/10.1083/jcb.201009094
39. Rodier, F., J.P. Coppé, C.K. Patil, W.A. Hoeijmakers, D.P. Muñoz, S.R. Raza, A. Freund, E. Campeau, A.R. Davalos, and J. Campisi. 2009. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat. Cell Biol. 11:973-979. http://dx.doi.org/10.1038/ncb1909
40. Rodier, F., D.P. Muñoz, R. Teachenor, V. Chu, O. Le, D. Bhaumik, J.P. Coppé, E. Campeau, C.M. Beauséjour, S.H. Kim, et al. 2011. DNASCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion. J. Cell Sci. 124:68-81. http://dx.doi.org/10.1242/jcs.071340
41. Sagiv, A., A. Biran, M. Yon, J. Simon, S.W. Lowe, and V. Krizhanovsky. 2013. Granule exocytosis mediates immune surveillance of senescent cells. Oncogene. 32:1971-1977. http://dx.doi.org/10.1038/onc.2012.206
42. Serrano, M., A.W. Lin, M.E. McCurrach, D. Beach, and S.W. Lowe. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 88:593-602. http://dx.doi.org/10.1016/S0092-8674(00)81902-9
43. Tang, X., M. Asano, A. O'Reilly, A. Farquhar, Y. Yang, and S. Amar. 2012. p53 is an important regulator of CCL2 gene expression. Curr. Mol. Med. 12:929-943. http://dx.doi.org/10.2174/156652412802480844
44. Textor, S., N. Fiegler, A. Arnold, A. Porgador, T.G. Hofmann, and A. Cerwenka. 2011. Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2. Cancer Res. 71:5998-6009. http://dx.doi.org/10.1158/0008-5472.CAN-10-3211
45. Tokuyama, M., C. Lorin, F. Delebecque, H. Jung, D.H. Raulet, and L. Coscoy. 2011. Expression of the RAE-1 family of stimulatory NK-cell ligands requires activation of the PI3K pathway during viral infection and transformation. PLoS Pathog. 7:e1002265. http://dx.doi.org/10.1371/journal.ppat.1002265
46. Ventura, A., D.G. Kirsch, M.E. McLaughlin, D.A. Tuveson, J. Grimm, L. Lintault, J. Newman, E.E. Reczek, R. Weissleder, and T. Jacks. 2007. Restoration of p53 function leads to tumour regression in vivo. Nature. 445:661-665. http://dx.doi.org/10.1038/nature05541
47. Vivier, E., D.H. Raulet, A. Moretta, M.A. Caligiuri, L. Zitvogel, L.L. Lanier, W.M. Yokoyama, and S. Ugolini. 2011. Innate or adaptive immunity? Theexample of natural killer cells. Science. 331:44-49. http://dx.doi.org/10.1126/science.1198687
48. Wajapeyee, N., R.W. Serra, X. Zhu, M. Mahalingam, and M.R. Green. 2008. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell. 132:363-374. http://dx.doi.org/10.1016/j.cell.2007.12.032
49. Walzer, T., and E. Vivier. 2011. G-protein-coupled receptors in control of natural killer cell migration. Trends Immunol. 32:486-492. http://dx.doi.org/10.1016/j.it.2011.05.002
50. Xue, W., L. Zender, C. Miething, R.A. Dickins, E. Hernando, V. Krizhanovsky, C. Cordon-Cardo, and S.W. Lowe. 2007. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature. 445:656-660. http://dx.doi.org/10.1038/nature05529
51. Yang, G., D.G. Rosen, Z. Zhang, R.C. Bast Jr., G.B. Mills, J.A. Colacino, I. Mercado-Uribe, and J. Liu. 2006. The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Proc. Natl. Acad. Sci. USA. 103:16472-16477. http://dx.doi.org/10.1073/pnas.0605752103